News
A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...
15-year-old Nolan Grove testified in his homicide trial, claiming the shooting of 12-year-old Kain Heiland was accidental. Surveillance footage tracked the boys' movements leading up to the ...
Dr. Albert J. Polito from Mercy Medical Center joins Jenyne for a conversation about lung conditions such as COPD and asthma and how they present in female patients.
15-year-old Nolan Grove testified in his homicide trial, claiming the shooting of 12-year-old Kain Heiland was accidental. Surveillance footage tracked the boys' movements leading up to the ...
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.
Merck spends $10 billion for Verona, gaining access to its COPD medication Ohtuvayre was launched as the first commercial product for London-based Verona Pharma. The drug also is being studied as ...
15-year-old Nolan Grove testified in his homicide trial, claiming the shooting of 12-year-old Kain Heiland was accidental. Surveillance footage tracked the boys' movements leading up to the ...
Raleigh’s Verona Pharma acquired by Merck for $10 billion as maker of COPD treatment Ohtuvayre merges with pharmaceutical company with growing Durham, NC footprint ...
15-year-old Nolan Grove testified in his homicide trial, claiming the shooting of 12-year-old Kain Heiland was accidental. Surveillance footage tracked the boys' movements leading up to the ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new ch… ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results